Rare lung cancer medication made available on the PBS

The Liberal National Government will make a medicine for a rare type of lung cancer caused by a gene defect affordable, saving patients $140,000 a year.   From 1 January the medicine Xalkori® (crizotinib) will made available through the Pharmaceutical Benefits Scheme (PBS) for lung cancer patients with a c-ROS proto-oncogene 1 (ROS1) gene rearrangement.…